Genome-scale overexpression screen reveals membrane homeostasis as a key determinant for free fatty acids overproduction in Escherichia coli.

Metab Eng

State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China; Frontier Science Center for Synthetic Biology (Ministry of Education), School of Synthetic Biology and Biomanufacturing, Tianjin University, Tianjin, 300072, China. Electronic address:

Published: November 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Genome-scale target identification is essential for optimizing microbial biosynthesis due to the highly complex and interconnected nature of cellular metabolism. Free fatty acids (FFAs), valuable precursors for biofuels and industrial chemicals, have been extensively studied in Escherichia coli. However, genome-wide exploration of beneficial targets that promote FFAs production remains limited, hindering efforts to fully unlock the potential of microbial biosynthetic capabilities. In this study, we performed genome-scale screening of upregulation targets for FFAs overproduction in E. coli by leveraging the ASKA (A Complete Set of E. coli K-12 ORF Archive) library in combination with fluorescence-activated cell sorting (FACS) and next-generation sequencing (NGS). We found that overexpression of rfaY, encoding a lipopolysaccharide (LPS) core heptose II phosphokinase, led to a 207.8% increase in FFAs production by enhancing membrane stability, as evidenced by reduced permeability and improved integrity. Further investigation revealed that overexpressing additional LPS biosynthesis-related genes similarly improved membrane robustness and FFAs production. Through iterative screening, yafL and rimM were identified as synergistic partners with rfaY, and subsequent integration of fadR overexpression ultimately yielded the optimal strain rfaY-yafL-fadR, which achieved a FFAs titer of 39.6 g/L under fed-batch fermentation-the highest reported to date in E. coli. This study highlights the significance of genome-scale mining potential genetic determinants for enhancing the biosynthesis of desired products.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymben.2025.07.002DOI Listing

Publication Analysis

Top Keywords

ffas production
12
free fatty
8
fatty acids
8
escherichia coli
8
ffas
6
coli
5
genome-scale
4
genome-scale overexpression
4
overexpression screen
4
screen reveals
4

Similar Publications

Metabolic stress and negative energy balance (NEB) are typical undesirable accompanying phenomenon of the post-partum period in dairy cattle. They negatively affect not only milk production but also the reproductive abilities of the cow, and it is therefore desirable to recognize NEB early to prevent its development. Metabolic stress markers are traditionally total cholesterol (tChol), non-esterified fatty acids (NEFA), beta-hydroxybutyrate (BHB) and triacylglycerols (TAGs).

View Article and Find Full Text PDF

The study aimed to determine whether confinement with TMR during the first 21 DIM, followed by grazing supplemented with partial mixed ration (PMR), alleviates negative energy balance, enhancing productive performance and accelerating the resumption of ovarian cyclicity in primiparous and multiparous dairy cows, relative to a control group managed on grazing supplemented with PMR after calving. Following calving, 16 primiparous and 24 multiparous Holstein dairy cows were blocked and randomly distributed into 2 treatments: one included grazing plus supplementation with PMR after calving (T0), while the other one involved confinement with TMR ad libitum during the first 21 DIM and the same feeding management of T0 from d 22 onwards until 60 DIM (T21). Primiparous cows showed no significant differences between treatments in milk production.

View Article and Find Full Text PDF

Sclareol mitigates steatosis, inflammation, and fibrosis through the regulation of AMPK/SREBP1/NF-κB/TGF-β pathways in metabolic dysfunction-associated steatohepatitis.

Biomed Pharmacother

September 2025

Department of Pharmacology, Central University of Punjab, Bathinda, Punjab 151401, India; Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH Aachen University Hospital, Aachen, Germany. Electronic address:

Metabolic dysfunction-associated steatohepatitis (MASH) is the progressive form of metabolic dysfunction-associated steatotic liver disease (MASLD). The increasing burden of MASH and its associated complications is challenging to cure. Our study aims to investigate the therapeutic potential of sclareol in MASH pathogenesis.

View Article and Find Full Text PDF

This study evaluated the beneficial effects of pumpkin polysaccharide (PPS3) on diet-induced obesity in mice and explored its underlying mechanisms. In a 10-week study, PPS3 significantly reduced body weight without affecting food or water intake, indicating a direct metabolic effect. PPS3 improved lipid and glucose metabolism by lowering serum triglycerides, total cholesterol, and non-esterified fatty acids, while increasing HDL cholesterol and enhancing glucose tolerance.

View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic hepatopathy and a leading precursor of hepatocellular carcinoma (HCC) worldwide. Initially attributed to insulin resistance (IR)-driven metabolic imbalance, recent insights highlight a multifactorial pathogenesis involving oxidative stress (OS), chronic inflammation, and immune dysregulation. The hepatic accumulation of free fatty acids (FFAs) initiates mitochondrial dysfunction and excessive reactive oxygen species (ROS) production, culminating in lipotoxic intermediates and mitochondrial DNA damage.

View Article and Find Full Text PDF